These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1170302)
1. [Dissolution behavior of solid drugs. IV. Determination of effective surface areas of pharmaceutical powders by dissolution rate measurements (author's transl)]. Sekiguchi K; Shirotani K; Kanke M Yakugaku Zasshi; 1975 Feb; 95(2):195-203. PubMed ID: 1170302 [No Abstract] [Full Text] [Related]
2. [Comparative study of the behaviour of various types of phenacetin on compression and dissolution characteristics (author's transl)]. Tshimpangila D; Delattre L J Pharm Belg; 1978; 33(6):387-96. PubMed ID: 748524 [No Abstract] [Full Text] [Related]
3. [Dissolution of drug powders. I. Dissolution of monodisperse powders (author's transl)]. Matsuura I Yakugaku Zasshi; 1982 Mar; 102(3):264-71. PubMed ID: 7108756 [No Abstract] [Full Text] [Related]
4. [Pharmaceutical studies on physical properties of solid form drugs. IV. Behavior of powders in tabletting (author's transl)]. Kigasawa K; Iimura H; Tanizaki A; Sugahara S; Watabe K; Sugimura H; Shimizu H Yakugaku Zasshi; 1979 Jul; 99(7):723-9. PubMed ID: 544790 [No Abstract] [Full Text] [Related]
5. Proceedings: Dissolution rate and the surface area of compacted powder systems. Armstrong NA; Haines-Nutt RF J Pharm Pharmacol; 1973 Dec; 25():Suppl:147P. PubMed ID: 4150551 [No Abstract] [Full Text] [Related]
6. [The determination and interpretation of in-vitro dissolution behavior of pharmaceutical substances. 1. Powders, mixtures and granules]. Voigt R; Eitz K; Bornschein M Pharmazie; 1987 Jan; 42(1):22-5. PubMed ID: 3575398 [TBL] [Abstract][Full Text] [Related]
7. [Technological methods for improving the solubility and increasing the dissolution rate of slightly soluble drugs (author's transl)]. Krowczynski L Pharmazie; 1982 Jan; 37(1):79-83. PubMed ID: 7071117 [No Abstract] [Full Text] [Related]
8. Dissolution of slightly soluble drugs. III. Surface condition of powder particles and their initial dissolution behavior. Kaneniwa N; Watari N Chem Pharm Bull (Tokyo); 1977 May; 25(5):867-75. PubMed ID: 264180 [No Abstract] [Full Text] [Related]
9. [Study of the influence of particle size and lactose on the dissolution of phenacetin and acetanilide capsules using a multiple regression method (author's transl)]. Gurny R; Boymond-Genoud M; Guitard P J Pharm Belg; 1978; 33(1):6-10. PubMed ID: 660407 [No Abstract] [Full Text] [Related]
10. [Biopharmaceutical studies of drug. IV. Studies on the improvement of dissolution properties and gastrointestinal absorption of 2-oxo-3-[4-(1-oxo-2-isoindolinyl)phenyl]butanamide (author's transl)]. Kigasawa K; Maruyama K; Tanaka M; Koyama O; Watabe K Yakugaku Zasshi; 1981 Aug; 101(8):723-32. PubMed ID: 7328496 [No Abstract] [Full Text] [Related]
11. [Studies on the dissolution test of the solid dosage form. I. Correlation of bioavailability and dissolution rate of isonicotinic acid hydrazide tablet (author's transl)]. Ogata H; Suzuki S; Shibazaki T; Ejima A; Inoue T Yakugaku Zasshi; 1978 Jul; 98(7):823-31. PubMed ID: 712546 [No Abstract] [Full Text] [Related]
12. [Biopharmaceutical studies of drugs. V. Dissolution properties and bioavailability of ground mixtures of poorly water soluble drugs and soluble proteins (author's transl)]. Kigasawa K; Maruyama K; Tanaka M; Watabe K; Koyama O Yakugaku Zasshi; 1981 Aug; 101(8):733-9. PubMed ID: 7328497 [No Abstract] [Full Text] [Related]
13. Mechanism of dissolution. IV. Verification of effective interfacial concentration during dissolution of a solid. Shively CD; Kildsig DO J Pharm Sci; 1972 Oct; 61(10):1589-93. PubMed ID: 5072406 [No Abstract] [Full Text] [Related]
14. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000. Khan S; Batchelor H; Hanson P; Perrie Y; Mohammed AR J Pharm Sci; 2011 Oct; 100(10):4281-94. PubMed ID: 21560130 [TBL] [Abstract][Full Text] [Related]
15. [Pharmaceutical studies on physical properties of powders. IV. Study on the estimation of flow rate through horizontal circular orifice (author's transl)]. Kigazawa K; Iimura H; Watabe K Yakugaku Zasshi; 1974 Jan; 94(1):88-92. PubMed ID: 4859052 [No Abstract] [Full Text] [Related]
17. New method for characterizing dissolution properties of drug powders. Pedersen PV J Pharm Sci; 1977 Jun; 66(6):761-6. PubMed ID: 406380 [TBL] [Abstract][Full Text] [Related]
18. [Packing-property of pharmaceutical powders. VI. Relationship between compacting progress and measurements variation of apparent density in course of packing of pharmaceutical powders (author's transl)]. Miyake Y; Toyoshima S; Takenaka H Yakugaku Zasshi; 1976 Jan; 96(1):116-21. PubMed ID: 943501 [No Abstract] [Full Text] [Related]
19. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus. Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799 [TBL] [Abstract][Full Text] [Related]
20. Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin. Li Y; Rantanen J; Yang M; Bohr A Eur J Pharm Sci; 2019 Mar; 129():1-9. PubMed ID: 30553059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]